CALADRIUS BIOSCIENCES, INC. (38) | Human Resources (6)

Browse by Subcategory

Compensation Agreements (1 contract)
Employment Agreements (5)

Recent Contracts

Employment Agreement, dated as of September 15, 2022, by and between Lisata Therapeutics and David Slack (Filed With SEC on September 15, 2022)
Director Compensation Policy (filed as Exhibit 10.1 to the Companys Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 22, 2018 and... (Filed With SEC on March 14, 2019)
Amendment, dated as of January 16, 2015, to Employment Agreement, dated as of January 5, 2015 and effective on January 5, 2015, by and between Caladrius and David J. Mazzo, Ph.D.... (Filed With SEC on June 15, 2022)
Employment Agreement, dated March 29, 2021, by and between Cend Therapeutics, Inc. and David Slack (Filed With SEC on June 15, 2022)
Amended and Restated Employment Agreement, dated as of March 19, 2021, by and between the Company and David J. Mazzo, Ph. D (Filed With SEC on March 19, 2021)
Offer Letter Amendment dated October 6, 2015, to Employment Agreement dated June 28, 2011 and effective October 6, 2015, by and between the Company and Joseph Talamo (Filed With SEC on March 14, 2019)